Tumor resensitization to erlotini... [Cancer Chemother Pharmacol. 2008] - PubMed

Supplemental Content

Save items

Related citations in PubMed

Dual inhibition of the epidermal growth factor receptor with cetuximab, an IgG1 monoclonal antibody, and gefitinib, a tyrosine kinase inhibitor, in patients with refractory non-small cell lung cancer (NSCLC): a phase I study. [J Thorac Oncol. 2008]
Dual inhibition of the epidermal growth factor receptor with cetuximab, an IgG1 monoclonal antibody, and gefitinib, a tyrosine kinase inhibitor, in patients with refractory non-small cell lung cancer (NSCLC): a phase I study.
Ramalingam S, Forster J, Naret C, Evans T, Sulecki M, Lu H, Teegarden P, Weber MR, Belani CP. J Thorac Oncol. 2008 Mar; 3(3):258-64.
Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers. [Clin Cancer Res. 2008]
Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers.
Fichtner I, Rolff J, Soong R, Hoffmann J, Hammer S, Sommer A, Becker M, Merk J. Clin Cancer Res. 2008 Oct 15; 14(20):6456-68.
Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer. [Int J Oncol. 2008]
Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
Oliveras-Ferraros C, Vazquez-Martin A, López-Bonet E, Martín-Castillo B, Del Barco S, Brunet J, Menendez JA. Int J Oncol. 2008 Dec; 33(6):1165-76.
Review Epidermal growth factor receptor in relation to tumor development: EGFR-targeted anticancer therapy. [FEBS J. 2010]
Review Epidermal growth factor receptor in relation to tumor development: EGFR-targeted anticancer therapy.
Okamoto I. FEBS J. 2010 Jan; 277(2):309-15. Epub 2009 Nov 18.
Review Epidermal growth factor receptor (EGFR) targeted therapies in non-small cell lung cancer (NSCLC). [Rev Recent Clin Trials. 2006]
Review Epidermal growth factor receptor (EGFR) targeted therapies in non-small cell lung cancer (NSCLC).
Metro G, Finocchiaro G, Toschi L, Bartolini S, Magrini E, Cancellieri A, Trisolini R, Castaldini L, Tallini G, Crino L, et al. Rev Recent Clin Trials. 2006 Jan; 1(1):1-13.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Tumor resensitization to erlotinib following brief substitution of cetuximab.
Tumor resensitization to erlotinib following brief substitution of cetuximab.
Cancer Chemother Pharmacol. 2008 Nov ;62(6):1111-2. Epub 2008 Feb 19 .

PubMed
Role of endotoxin in the pathogenesis of critical illness polyneuropathy.
Role of endotoxin in the pathogenesis of critical illness polyneuropathy.
J Neurol. 2008 Feb ;255(2):265-72. Epub 2008 Feb 20 .

PubMed
The auditory startle response in parkinsonism may reveal the extent but not type...
The auditory startle response in parkinsonism may reveal the extent but not type of pathology.
J Neurol. 2008 May ;255(5):628-32. Epub 2008 Feb 19 .

PubMed
The effects of low doses of n-3 fatty acid supplementation on blood pressure in ...
The effects of low doses of n-3 fatty acid supplementation on blood pressure in hypertensive subjects. A randomized controlled trial.
Arch Intern Med. 1991 Jun ;151(6):1173-80.

PubMed
Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cel...
Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells.
Neoplasia. 2008 Feb ;10(2):140-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Tumor resensitization to erlotinib following brief substitution of cetuximab.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information